Cell Culture Media Market (By Product: Serum-free Media, Stem Cell Culture Media; By Type: Liquid Media, Semi-solid And Solid Media; By Application; By End-use) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

The global cell culture media market size was surpassed at USD 4.77 billion in 2023 and is expected to hit around USD 15.59 billion by 2033, growing at a CAGR of 12.57% from 2024 to 2033. The cell culture media market is driven by advancements in biotechnology, pharmaceutical research, and increasing demand for cell-based therapies.

Cell Culture Media Market Size 2024 to 2033

 

Key Pointers

  • North America dominated the global market with the largest market share of 38% in 2023.
  • Asia Pacific is anticipated to exhibit the fastest CAGR of 14.96% from 2024 to 2033.
  • By Product, the serum-free media (SFM) segment held the largest revenue share of 37% in 2023.
  • By Application, the biopharmaceutical production segment generated the maximum market share of 43% in 2023.
  • By Type, the liquid media segment captured the maximum market share of 63% in 2023.
  • By End-use, the pharmaceutical and biotechnology companies segment had the largest market share of 35% in 2023.

Cell Culture Media Market Growth

The robust expansion of the cell culture media market can be attributed to several key growth factors. Firstly, advancements in biotechnology and pharmaceutical research have spurred the demand for sophisticated cell culture media, fostering enhanced cell growth and viability. Additionally, the increasing focus on personalized medicine and the development of novel biopharmaceuticals has driven substantial investments in research and development, propelling the market forward. Moreover, the application of cell culture media in biopharmaceutical production, cancer research, and stem cell studies has broadened, contributing to the market's sustained growth. The integration of advanced technologies like 3D cell culture and microfluidics has further augmented the efficiency and relevance of cell culture systems. Furthermore, favorable regulatory frameworks and increasing support for cell-based therapies create a conducive environment for market expansion, encouraging stakeholders to explore and invest in this dynamic sector.

Cell Culture Media Market Trends:

  • Diversification of Applications: The versatile nature of cell culture media is leading to its expanding applications, particularly in biopharmaceutical production, cancer research, and stem cell studies. This diversification is not only broadening the market's reach but also positioning it as a crucial component across various domains within the life sciences.
  • Rising Demand for Personalized Medicine: The growing emphasis on personalized medicine is a key trend propelling the cell culture media market. As the healthcare industry increasingly focuses on tailored therapeutic solutions, the demand for cell culture media that supports the development of personalized treatments and therapies continues to rise.
  • Integration of Automation: Automation is becoming prevalent in cell culture processes, leading to increased efficiency, reproducibility, and scalability. The integration of automated systems in cell culture media preparation and handling is streamlining workflows, reducing errors, and enhancing overall productivity.
  • Focus on Sustainability: Sustainability is emerging as a noteworthy trend in the cell culture media market. Stakeholders are increasingly exploring environmentally friendly alternatives and processes, aligning with global efforts to promote sustainable practices in the life sciences industry.
  • Rising Demand for Animal Component-Free Media: The market is witnessing a growing demand for animal component-free cell culture media, driven by the need to address ethical concerns, ensure product safety, and comply with regulatory guidelines. This trend reflects a broader industry shift towards more ethical and well-defined media formulations.
  • Regulatory Support for Cell-Based Therapies: Favorable regulatory frameworks and increasing support for cell-based therapies are providing a strong impetus to the market. Regulatory encouragement is fostering an environment conducive to the development and commercialization of cell culture media for therapeutic applications, further driving market growth.

Product Insights

The serum-free media (SFM) segment secured the highest market share, accounting for 37% in 2023. Serum-free media play a pivotal role as a valuable tool, enabling researchers to conduct specific applications or cultivate particular cell types without the need for serum. Utilizing serum-free media provides several advantages, including enhanced growth and productivity, consistent performance, improved control over physiological sensitivity, and a reduced risk of infection by serum-borne adventitious agents in the culture.

Furthermore, the adoption of serum-free alternatives aligns with the prioritization of animal welfare, emerging as a primary driver for their widespread use. The field of gene and cell therapy is experiencing rapid growth, with regulatory guidelines from the Food and Drug Administration (FDA) emphasizing tighter control over raw materials to ensure the reliable and safe manufacturing of drug products. Employing SFM presents an opportunity to develop more reproducible formulations, thereby minimizing batch-to-batch variability. This underscores the significance of serum-free media in meeting evolving industry demands and regulatory standards.

Application Insights

In 2023, the biopharmaceutical production segment emerged as the market leader, commanding a substantial revenue share of 43%. This dominance is attributed to the escalating demand within the biopharmaceutical industry for media that is not only more reproducible but also better-defined, addressing the need to accommodate increasing production levels while mitigating the risk of contamination in downstream processes.

Furthermore, the growth of this segment is propelled by strategic initiatives undertaken by key biopharmaceutical companies. A notable example occurred in July 2021, when Cytiva and Pall Corporation jointly invested USD 1.5 billion over a two-year period to meet the surging demand for biotechnology solutions. A significant portion of this investment, exceeding USD 400 million, is allocated for the development of culture media in powder or liquid form. Additionally, these companies plan to expand their operations in the United States, Austria, and the United Kingdom, further contributing to the growth of the biopharmaceutical production segment.

Type Insights

In 2023, the liquid media segment claimed the highest revenue share at 63%. This dominance can be attributed to a growing trend among both downstream and upstream manufacturers of biologics and biosimilars, who are increasingly transitioning from premixed powders to liquid media. This shift is motivated by factors such as rapid mycobacterial growth, high isolation rates, and the simplification of manufacturing processes. Liquid media not only eliminates certain process steps but also reduces the likelihood of hazardous exposure, offering a more flexible and straightforward approach to both manufacturing and development compared to powdered media.

Cell Culture Media Market Share, By Type, 2023 (%)

Moreover, the adoption of ready-to-use liquid media eliminates the necessity for mixing containers, balances, and the installation of a water for injection (WFI) loop, which is typically required for mixing powdered media. The segment's growth is further propelled by strategic initiatives undertaken by manufacturers. For example, in June 2021, Sartorius inaugurated a new facility in Israel, dedicated to customized and specialty cell culture primarily for the advanced therapies market. This facility is poised to play a significant role as a production site for buffers and liquid cell culture, contributing to the momentum of the liquid media segment.

End-use Insights

In 2023, the pharmaceutical and biotechnology companies segment emerged as the leader, securing the highest revenue share at 35%. The surge in demand for cell culture products is propelled by the ongoing expansion of manufacturing capacities in the biopharmaceutical sector. Notably, in September 2020, Cytiva announced a significant expansion of its manufacturing capacity, accompanied by extensive personnel recruitment to support the growth of the biotechnology industry. The company has earmarked an investment of approximately USD 500 million over five years to bolster its manufacturing capabilities.

Furthermore, the increasing number of clinical trials presents lucrative opportunities in the foreseeable future. In 2021, industry-sponsored trials in progress for regenerative medicine witnessed a notable increase of 100 compared to 2020, reaching a total of 1,320. This growth was complemented by an additional 1,328 regenerative medicine trials supported globally by non-industry entities such as government entities and academic centers. The expanding landscape of clinical trials signifies a heightened demand for cell culture products within the pharmaceutical and biotechnology companies segment.

Regional Insights

In 2023, North America emerged as the dominant force in the regional market, securing a substantial revenue share of 38%. This prominence can be attributed to the robust growth in the pharmaceutical and biotechnology industries, a surge in approvals for cell culture-based vaccines, and an increasing incidence of diseases such as cancer. The region also benefits from significant investments and funding directed towards cell-based research.

Cell Culture Media Market Share, By Region, 2023 (%)

On the other hand, Asia Pacific is anticipated to exhibit the fastest Compound Annual Growth Rate (CAGR) of 14.96% during the forecast period. This growth is driven by a heightened awareness of the advantages associated with the use of cell culture techniques. Additionally, strategic initiatives by key market players to expand their footprint in Asia Pacific countries, aiming to capture a substantial market share, are poised to present lucrative opportunities. For instance, in December 2021, Fujifilm Irvine Scientific, Inc. initiated the construction of a new bioprocessing center in China. The objective is to provide support for cell culture media optimization, particularly for the development of biotherapeutic drugs, vaccines, and advanced therapies. This move underlines the growing importance of the Asia Pacific region in the cell culture media market.

Cell Culture Media Market Key Companies

  • Sartorius AG
  • Danaher
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • FUJIFILM Corporation
  • Lonza
  • BD
  • STEMCELL Technologies
  • Cell Biologics, Inc.
  • PromoCell GmbH

Cell Culture Media Market Segmentations:

By Product

  • Serum-free Media
    • CHO Media   
    • BHK Medium         
    • Vero Medium         
    • HEK 293 Media        
    • Other Serum-free media
  • Classical Media
  • Stem Cell Culture Media
  • Specialty Media
  • Chemically Defined Media
  • Other Cell Culture Media

By Application

  • Biopharmaceutical Production
    • Monoclonal Antibodies
    • Vaccines Production
    • Other Therapeutic Proteins
  • Diagnostics
  • Drug Screening And Development
  • Tissue Engineering And Regenerative Medicine
    • Cell And Gene Therapy
    • Other Tissue Engineering And Regenerative Medicine Applications
  • Other Applications

By Type

  • Liquid Media
  • Semi-solid And Solid Media

By End-use

  • Pharmaceutical And Biotechnology Companies
  • Hospitals And Diagnostic Laboratories
  • Research And Academic Institutes
  • Other End-users

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Frequently Asked Questions

The global cell culture media market size was reached at USD 4.77 billion in 2023 and it is projected to hit around USD 15.59 billion by 2033.

The global cell culture media market is growing at a compound annual growth rate (CAGR) of 12.57% from 2024 to 2033.

The North America region has accounted for the largest cell culture media market share in 2023.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Cell Culture Media Market 

5.1. COVID-19 Landscape: Cell Culture Media Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Cell Culture Media Market, By Product

8.1. Cell Culture Media Market, by Product, 2024-2033

8.1.1. Serum-free Media

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Classical Media

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Stem Cell Culture Media

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Specialty Media

8.1.4.1. Market Revenue and Forecast (2021-2033)

8.1.6. Chemically Defined Media

8.1.6.1. Market Revenue and Forecast (2021-2033)

8.1.7. Other Cell Culture Media

8.1.7.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Cell Culture Media Market, By Application

9.1. Cell Culture Media Market, by Application e, 2024-2033

9.1.1. Biopharmaceutical Production

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Diagnostics

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Drug Screening And Development

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Tissue Engineering And Regenerative Medicine

9.1.4.1. Market Revenue and Forecast (2021-2033)

9.1.5. Other Applications

9.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Cell Culture Media Market, By Type 

10.1. Cell Culture Media Market, by Type, 2024-2033

10.1.1. Liquid Media

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Semi-solid And Solid Media

10.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Cell Culture Media Market, By End-user 

11.1. Cell Culture Media Market, by End-user, 2024-2033

11.1.1. Pharmaceutical And Biotechnology Companies

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Hospitals And Diagnostic Laboratories

11.1.2.1. Market Revenue and Forecast (2021-2033)

11.1.3. Research And Academic Institutes

11.1.3.1. Market Revenue and Forecast (2021-2033)

11.1.4. Other End-users

11.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Cell Culture Media Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2021-2033)

12.1.2. Market Revenue and Forecast, by Application (2021-2033)

12.1.3. Market Revenue and Forecast, by Type (2021-2033)

12.1.4. Market Revenue and Forecast, by End-user (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.1.5.2. Market Revenue and Forecast, by Application (2021-2033)

12.1.5.3. Market Revenue and Forecast, by Type (2021-2033)

12.1.5.4. Market Revenue and Forecast, by End-user (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.1.6.2. Market Revenue and Forecast, by Application (2021-2033)

12.1.6.3. Market Revenue and Forecast, by Type (2021-2033)

12.1.6.4. Market Revenue and Forecast, by End-user (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.2. Market Revenue and Forecast, by Application (2021-2033)

12.2.3. Market Revenue and Forecast, by Type (2021-2033)

12.2.4. Market Revenue and Forecast, by End-user (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.5.2. Market Revenue and Forecast, by Application (2021-2033)

12.2.5.3. Market Revenue and Forecast, by Type (2021-2033)

12.2.5.4. Market Revenue and Forecast, by End-user (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.6.2. Market Revenue and Forecast, by Application (2021-2033)

12.2.6.3. Market Revenue and Forecast, by Type (2021-2033)

12.2.6.4. Market Revenue and Forecast, by End-user (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.7.2. Market Revenue and Forecast, by Application (2021-2033)

12.2.7.3. Market Revenue and Forecast, by Type (2021-2033)

12.2.7.4. Market Revenue and Forecast, by End-user (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.8.2. Market Revenue and Forecast, by Application (2021-2033)

12.2.8.3. Market Revenue and Forecast, by Type (2021-2033)

12.2.8.4. Market Revenue and Forecast, by End-user (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.2. Market Revenue and Forecast, by Application (2021-2033)

12.3.3. Market Revenue and Forecast, by Type (2021-2033)

12.3.4. Market Revenue and Forecast, by End-user (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.5.2. Market Revenue and Forecast, by Application (2021-2033)

12.3.5.3. Market Revenue and Forecast, by Type (2021-2033)

12.3.5.4. Market Revenue and Forecast, by End-user (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.6.2. Market Revenue and Forecast, by Application (2021-2033)

12.3.6.3. Market Revenue and Forecast, by Type (2021-2033)

12.3.6.4. Market Revenue and Forecast, by End-user (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.7.2. Market Revenue and Forecast, by Application (2021-2033)

12.3.7.3. Market Revenue and Forecast, by Type (2021-2033)

12.3.7.4. Market Revenue and Forecast, by End-user (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.8.2. Market Revenue and Forecast, by Application (2021-2033)

12.3.8.3. Market Revenue and Forecast, by Type (2021-2033)

12.3.8.4. Market Revenue and Forecast, by End-user (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.2. Market Revenue and Forecast, by Application (2021-2033)

12.4.3. Market Revenue and Forecast, by Type (2021-2033)

12.4.4. Market Revenue and Forecast, by End-user (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.5.2. Market Revenue and Forecast, by Application (2021-2033)

12.4.5.3. Market Revenue and Forecast, by Type (2021-2033)

12.4.5.4. Market Revenue and Forecast, by End-user (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.6.2. Market Revenue and Forecast, by Application (2021-2033)

12.4.6.3. Market Revenue and Forecast, by Type (2021-2033)

12.4.6.4. Market Revenue and Forecast, by End-user (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.7.2. Market Revenue and Forecast, by Application (2021-2033)

12.4.7.3. Market Revenue and Forecast, by Type (2021-2033)

12.4.7.4. Market Revenue and Forecast, by End-user (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.8.2. Market Revenue and Forecast, by Application (2021-2033)

12.4.8.3. Market Revenue and Forecast, by Type (2021-2033)

12.4.8.4. Market Revenue and Forecast, by End-user (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.5.2. Market Revenue and Forecast, by Application (2021-2033)

12.5.3. Market Revenue and Forecast, by Type (2021-2033)

12.5.4. Market Revenue and Forecast, by End-user (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.5.5.2. Market Revenue and Forecast, by Application (2021-2033)

12.5.5.3. Market Revenue and Forecast, by Type (2021-2033)

12.5.5.4. Market Revenue and Forecast, by End-user (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.5.6.2. Market Revenue and Forecast, by Application (2021-2033)

12.5.6.3. Market Revenue and Forecast, by Type (2021-2033)

12.5.6.4. Market Revenue and Forecast, by End-user (2021-2033)

Chapter 13. Company Profiles

13.1. Thermo Fisher Scientific Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Merck KGaA

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. CYTIVA

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Sartorius AG

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. FUJIFILM Irvine Scientific, Inc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Lonza Group AG

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. InvivoGen

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. STEMCELL Technologies Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. PromoCell GmbH

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Cell Biologics, Inc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers